Chemo-immunotherapy induces tumor regression in a mouse model of spontaneous mammary carcinogenesis

SUPPLEMENTARY DATA
HER2
+ mammary carcinoma cell line generation and characterization
Tumor samples isolated from 129Sv-NeuT mice were freed from hemorrhagic and necrotic parts, washed in phosphate-buffered saline (PBS), finely minced with scissors and digested in a standard tissue culture grade trypsin-EDTA solution (0.5 mg/ml trypsin, 0.2 mg/ml EDTA, Life Technologies) at 37°C for 15 min; dissociated cells were washed twice in PBS and counted in a hemocytometer. Cells were seeded in tissue culture flasks in RPMI 1640 supplemented with 10% FBS (Life Technologies) and incubated at 37°C in a humidified 5% CO 2 atmosphere. Cultures were periodically washed briefly (1-2 min) with trypsin-EDTA to detach contaminating fibroblasts without damage to epithelial areas. When the epithelial monolayer reached confluency, usually 2-5 months after plating, cells were subcultured at low split ratios (usually 1:2). Established cell line named 676-1-25 was routinely subcultured twice weekly at 1:4-1:8 split ratios. For in vitro growth curve, cells were cultured in 24 well plates in triplicates at 2x10 4 cells per well, then harvested and counted at various times. For in vivo growth, healthy female 129Sv mice were used for the analysis of tumorigenicity of cultured cells. Briefly, tumors were induced by subcutaneous (s.c.) injection of varying amounts of 676-1-25 tumor cells as a single-cell suspension in PBS (0.2 ml/mouse). Tumor incidence and growth were evaluated twice weekly. Neoplastic masses were measured with caliper and the mean tumor diameter was calculated in 2 perpendicular major diameters. 
